COVID heralds a faster future for drug development (if stakeholders can collaborate)
UK AI leader welcomes increased investment but suggests more needs to be done.
Candidates slow down motor neurone death in patient samples.
Deal with MRCT will look for potential new drug targets and candidates.
BenevolentAI’s Judgment Augmented Cognition System will help develop the new drugs.